Compass Therapeutics, Inc. (CMPX) KPIs and segments

CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$0.83−0.01 (-0.93%)

Close on Nov 11, 2026Market cap $149.51MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Compass Therapeutics's business

Coming soon

This tab will track the numbers specific to Compass Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?